TSXV:PLRB - Pluribus Technologies
Youtube Pro Stock Picks

Click here to search for stock quotes, financial statistics and more.

or

Trending >

ADVERTISE WITH CANTECH

TOP PICKS

Analysts

Analysts Pharma and Biotech pmn
ProMIS Neurosciences has a 313 per cent upside, says Leede Jones Gable

Leede Jones Gable analyst Douglas Loe provided an update on Wednesday on drug developer ProMIS Neurosciences (ProMIS Neurosciences Stock Quote, Charts, News, Analysts, Financials TSX:PMN), saying strong clinical results from a peer company working on Alzheimer’s disease are a positive for ProMIS. Japan-based Eisai Co announced on Wednesday that its Phase 3 Clarity AD 1,795-patient […]

Cannabis Legalization
Analysts Cannabis faf hiti novc
Buy retail stocks over Canadian cannabis producers, ATB says

The industry is still finding its feet, now three years into legalized cannabis in Canada, and while licensed producers in the space remain challenged, investors should be looking at retail stocks. That’s the opinion of ATB Capital Markets, who on Tuesday published a research report arguing that valuations in the retail pot sector are looking […]

WELL Health
Share Tweet linked In Share

Get Stock Picks from the Pros.
In your Inbox.

On Wednesday, Algonquin Power announced it had secured a twenty-five year Power Purchase agreement with Sask Power for a 177 megawatt wind power project, beating out twenty-seven other proposals.

On Wednesday, Algonquin Power (TSX:AQN) announced it had secured a twenty-five year Power Purchase a...

Byron Capital analyst Tom Astle says that while there are many caveats to be aware of with Bombardier and its balance sheet, there appears to be more upside than downside in its share price.

On the first day of December last year, Bombardier (TSX:BBD.B) reported its Q3, 2011 results. The Ca...

Dr. Yves Fradet, President of Diagnocure. On Wednesday, Byron Capital analyst Douglas Loe upgraded the company to Buy from Speculative Buy because he says Diagnocure is no longer as subject to clinical or regulatory risk.

This past Wednesday DiagnoCure (TSX:CUR), along with its US-based partner Gen-Probe, received FDA ap...

Dacryocytes, or teardrop-shaped cells, are found in myelofibrosis and myelophthisic states of bone marrow. Mississauga's YM Bioscience's Myelofibrosis treatment, CYT387, has performed well in Phase Two trials. Byron Capital Healthcare analyst Douglas Loe thinks this may soon attract a larger

Last Thursday, YM Biosciences (TSX:YM) reported its Q2, 2012 results. The company lost $6.55-million...

Open Text's Q2 signals the end of the John Shackleton era and the beginning of the Mark Barrenechea era. On January 2nd, the former President and CEO of Rackable took the helm at Waterloo's second most well known company.

On Wednesday, Waterloo’s Open Text (TSX:OTC) surprised the street with a particularly strong Q...

Byron Capital analyst Tom Astle says there are are similarities and important differences between Thorsten Heins at RIM and Mike Zafirovski's introduction as Nortel CEO in November of 2005.

This past Thursday, in the basement of a steakhouse in Toronto, new Research in Motion CEO Thorsten ...

Harper:

It wasn’t potash, or gold, or even lumber. Today at the World Economic Forum in Davos, Switzer...

Will the rumoured May IPO of Facebook bring even more attention to social media stocks like Calgary's Poynt? Analyst Byron Berry says he is struck by the similarities between Poynt and San Francisco based IPO candidate Yelp.

In the public markets, the social media frenzy that will no doubt reach its pinnacle with the IPO of...

Last Friday, in a U.S. district court in Florida, Ottawa's Wi-LAN launched a patent suit against Research in Motion.

On Friday, about forty-eight hours before the surprising news broke that Thorsten Heins was named ne...

Could Mark Barrenechea, who became CEO of Waterloo's Open Text on January 2nd, be fielding offers for the company in 2012?

In 2011, the story of the year in Canadian tech was buyouts. Many of our most interesting Canadian c...

In order for any company to weather the many storms it is likely to encounter as it progresses from ...

Neptune Technologies

Neptune Technologies (TSXV:NTB) yesterday reported its Q3, 2012 results. The numbers appeared to be ...

Waddell:

In Canada, the shadow of Nortel is large and, seemingly, persistent. The fallen Ottawa tech giant, w...

Descartes Systems Group CEO Art Mesher. Versant Partners analyst Tom Liston has a $10 target on Descartes.

UPDATE! We’ve updated the analyst picks for 2013, check out the Top Picks of some of Canada...

The management team of Waterloo's Sandvine. Fiscal 2011 was a step backward for the company, which had been steadily improving for a number of years.

On Thursday, Sandvine (TSX:SVC) announced its fiscal 2011 results. Revenue came in at (US) $89.3 mil...

Al Hildebrandt, President and CEO of QHR Technologies. Versant Partners Tom Liston has a $1.30 target on the stock, which closed today at $.60 cents.

In an update to clients today, Versant Partners revealed its top picks for 2012. While the list is a...

Clearford Industries President and CEO Bruce Linton thinks the company's small bore sewer technology could be

After the recession of 2008, infrastructure spending seemed one of the better defensive places to be...

WELL Health
Share Tweet linked In Share

Get Stock Picks from the Pros. In your Inbox.

TRENDING

All Trending →
CGI

CGI is a shareholder-friendly tech stock, this investor says 

 June 15, 2022

VSBLTY Groupe Technologies has a 307 per cent upside, says Echelon

 June 15, 2022

Is Netflix a buy or sell right now?

 April 5, 2022
Wishpond

We’re bullish on Wishpond Technologies, says Beacon

 April 4, 2022

Three second quarter stock picks from Echelon Capital

 April 4, 2022